Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801378013> ?p ?o ?g. }
- W2801378013 endingPage "278" @default.
- W2801378013 startingPage "270" @default.
- W2801378013 abstract "Alzheimer's disease (AD) is characterized by progressive synaptic dysfunction and neuronal lost in specific brain areas including hippocampus, resulting in memory/learning deficits and cognitive impairments. In addition, non-cognitive symptoms are reported in AD patients, such as anxiety, apathy and depressed mood. The current antidepressant drugs present reduced efficacy to improve depressive symptoms in AD patients. Here, we investigated the ability of creatine, a compound with neuroprotective and antidepressant properties, to counteract amyloid β1–40 peptide-induced depressive-like behavior in mice. Moreover, we addressed the participation of the intracellular signaling pathway mediated by glycogen synthase kinase-3β (GSK-3β)/nuclear factor erythroid-2-related factor 2 (Nrf2) in the creatine effects. Aß1–40 administration (400 pmol/mouse, i.c.v.) increased the immobility time in the tail suspension test and decreased the grooming time and increased latency to grooming in the splash test, indicative of depressive-like behavior. These impairments were attenuated by creatine (0.01 and 10 mg/kg, p.o.) and fluoxetine (10 mg/kg, p.o., positive control). No significant alterations on locomotor performance were observed in the open field. Aß1–40 administration did not alter hippocampal phospho-GSK-3β (Ser9)/total GSK-3β, total GSK-3β and heme oxygenase-1 (HO-1) immunocontents. However, Aß1–40-infused mice treated with creatine (0.01 mg/kg) presented increased phosphorylation of GSK-3β(Ser9) and HO-1 immunocontent in the hippocampus. Fluoxetine per se increased GSK-3β(Ser9) phosphorylation, but did not alter HO-1 levels. In addition, Aß1–40 administration increased hippocampal glutathione (GSH) levels as well as glutathione reductase (GR) and thioredoxin reductase (TrxR) activities, and these effects were abolished by creatine and fluoxetine. This study provides the first evidence of the antidepressive-like effects of creatine in Aß1–40-treated mice, which were accompanied by hippocampal inhibition of GSK-3β and modulation of antioxidant defenses. These findings indicate the potential of creatine for the treatment of depression associated with AD." @default.
- W2801378013 created "2018-05-17" @default.
- W2801378013 creator A5016797870 @default.
- W2801378013 creator A5023515600 @default.
- W2801378013 creator A5026031815 @default.
- W2801378013 creator A5031221345 @default.
- W2801378013 creator A5047304660 @default.
- W2801378013 creator A5047721445 @default.
- W2801378013 creator A5048658931 @default.
- W2801378013 creator A5053652964 @default.
- W2801378013 creator A5061294250 @default.
- W2801378013 creator A5063116588 @default.
- W2801378013 date "2018-08-01" @default.
- W2801378013 modified "2023-10-17" @default.
- W2801378013 title "Antidepressant effects of creatine on amyloid β1–40-treated mice: The role of GSK-3β/Nrf2 pathway" @default.
- W2801378013 cites W1545899030 @default.
- W2801378013 cites W1582666826 @default.
- W2801378013 cites W1775749144 @default.
- W2801378013 cites W1967586038 @default.
- W2801378013 cites W1971233715 @default.
- W2801378013 cites W1973135990 @default.
- W2801378013 cites W1976202885 @default.
- W2801378013 cites W1979787619 @default.
- W2801378013 cites W1980739328 @default.
- W2801378013 cites W19851831 @default.
- W2801378013 cites W1988236146 @default.
- W2801378013 cites W1989801388 @default.
- W2801378013 cites W1996515322 @default.
- W2801378013 cites W1997072751 @default.
- W2801378013 cites W1998452120 @default.
- W2801378013 cites W2003598937 @default.
- W2801378013 cites W2004371621 @default.
- W2801378013 cites W2005243939 @default.
- W2801378013 cites W2005594217 @default.
- W2801378013 cites W2011811757 @default.
- W2801378013 cites W2013586266 @default.
- W2801378013 cites W2013704018 @default.
- W2801378013 cites W2014042119 @default.
- W2801378013 cites W2016356853 @default.
- W2801378013 cites W2022637707 @default.
- W2801378013 cites W2026261400 @default.
- W2801378013 cites W2032920422 @default.
- W2801378013 cites W2035090749 @default.
- W2801378013 cites W2035421865 @default.
- W2801378013 cites W2040536037 @default.
- W2801378013 cites W2040927330 @default.
- W2801378013 cites W2042751066 @default.
- W2801378013 cites W2052142284 @default.
- W2801378013 cites W2054145123 @default.
- W2801378013 cites W2056037521 @default.
- W2801378013 cites W2063487298 @default.
- W2801378013 cites W2063738240 @default.
- W2801378013 cites W2064922969 @default.
- W2801378013 cites W2065020384 @default.
- W2801378013 cites W2068698561 @default.
- W2801378013 cites W2072721338 @default.
- W2801378013 cites W2075790630 @default.
- W2801378013 cites W2079260094 @default.
- W2801378013 cites W2085577787 @default.
- W2801378013 cites W2086869917 @default.
- W2801378013 cites W2091588620 @default.
- W2801378013 cites W2093694233 @default.
- W2801378013 cites W2094185904 @default.
- W2801378013 cites W2096456417 @default.
- W2801378013 cites W2102343823 @default.
- W2801378013 cites W2103650142 @default.
- W2801378013 cites W2122937307 @default.
- W2801378013 cites W2123799789 @default.
- W2801378013 cites W2134031315 @default.
- W2801378013 cites W2146558971 @default.
- W2801378013 cites W2162853795 @default.
- W2801378013 cites W2169714384 @default.
- W2801378013 cites W2251475613 @default.
- W2801378013 cites W2268846735 @default.
- W2801378013 cites W2301692366 @default.
- W2801378013 cites W2307642644 @default.
- W2801378013 cites W2319767333 @default.
- W2801378013 cites W2394910669 @default.
- W2801378013 cites W2464950095 @default.
- W2801378013 cites W2499781989 @default.
- W2801378013 cites W2507341655 @default.
- W2801378013 cites W2512001536 @default.
- W2801378013 cites W2527824400 @default.
- W2801378013 cites W2529409407 @default.
- W2801378013 cites W2529847745 @default.
- W2801378013 cites W2580426974 @default.
- W2801378013 cites W2587497070 @default.
- W2801378013 cites W2770859047 @default.
- W2801378013 cites W2783814711 @default.
- W2801378013 cites W337699631 @default.
- W2801378013 cites W4211158689 @default.
- W2801378013 doi "https://doi.org/10.1016/j.pnpbp.2018.05.001" @default.
- W2801378013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29753049" @default.
- W2801378013 hasPublicationYear "2018" @default.
- W2801378013 type Work @default.
- W2801378013 sameAs 2801378013 @default.
- W2801378013 citedByCount "14" @default.
- W2801378013 countsByYear W28013780132019 @default.